|
1
|
Pera M: Epidemiology of esophageal cancer,
especially adenocarcinoma of the esophagus and esophagogastric
junction. Recent Results Cancer Res. 155:1–14. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Trivers KF, Sabatino SA and Stewart SL:
Trends in esophageal cancer incidence by histology, United States,
1998–2003. Int J Cancer. 123:1422–1428. 2008.
|
|
3
|
Breaux JR, Bringaze W, Chappuis C and Cohn
I Jr: Adenocarcinoma of the stomach: a review of 35 years and 1,710
cases. World J Surg. 14:580–586. 1990.PubMed/NCBI
|
|
4
|
Allum WH, Stenning SP, Bancewicz J, Clark
PI and Langley RE: Long-term results of a randomized trial of
surgery with or without preoperative chemotherapy in esophageal
cancer. J Clin Oncol. 27:5062–5067. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Burmeister BH, Smithers BM, Gebski V, et
al; Trans-Tasman Radiation Oncology Group; Australasian
Gastro-Intestinal Trials Group. Surgery alone versus
chemoradiotherapy followed by surgery for resectable cancer of the
oesophagus: a randomised controlled phase III trial. Lancet Oncol.
6:659–668. 2005. View Article : Google Scholar
|
|
6
|
Burmeister BH, Thomas JM, Burmeister EA,
et al: Is concurrent radiation therapy required in patients
receiving preoperative chemotherapy for adenocarcinoma of the
oesophagus? A randomised phase II trial. Eur J Cancer. 47:354–360.
2011. View Article : Google Scholar
|
|
7
|
Kelsen DP, Ginsberg R, Pajak TF, et al:
Chemotherapy followed by surgery compared with surgery alone for
localized esophageal cancer. N Engl J Med. 339:1979–1984. 1998.
View Article : Google Scholar
|
|
8
|
Urba SG, Orringer MB, Turrisi A,
Iannettoni M, Forastiere A and Strawderman M: Randomized trial of
preoperative chemoradiation versus surgery alone in patients with
locoregional esophageal carcinoma. J Clin Oncol. 19:305–313.
2001.
|
|
9
|
Walsh TN, Noonan N, Hollywood D, Kelly A,
Keeling N and Hennessy TP: A comparison of multimodal therapy and
surgery for esophageal adenocarcinoma. N Engl J Med. 335:462–467.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Hagen P, Hulshof MC, van Lanschot JJ,
et al; CROSS Group. Preoperative chemoradiotherapy for esophageal
or junctional cancer. N Engl J Med. 366:2074–2084. 2012.
|
|
11
|
Stahl M, Walz MK, Stuschke M, et al: Phase
III comparison of preoperative chemotherapy compared with
chemoradiotherapy in patients with locally advanced adenocarcinoma
of the esophagogastric junction. J Clin Oncol. 27:851–856. 2009.
View Article : Google Scholar
|
|
12
|
Sjoquist KM, Burmeister BH, Smithers BM,
et al; Australasian Gastro-Intestinal Trials Group. Survival after
neoadjuvant chemotherapy or chemoradiotherapy for resectable
oesophageal carcinoma: an updated meta-analysis. Lancet Oncol.
12:681–692. 2011. View Article : Google Scholar
|
|
13
|
Lutz MP, Zalcberg JR, Ducreux M, et al;
First St Gallen EORTC Gastrointestinal Cancer Conference 2012
Expert Panel. Highlights of the EORTC St. Gallen International
Expert Consensus on the primary therapy of gastric,
gastroesophageal and oesophageal cancer - differential treatment
strategies for subtypes of early gastroesophageal cancer. Eur J
Cancer. 48:2941–2953. 2012. View Article : Google Scholar
|
|
14
|
Siewert JR, Hölscher AH, Becker K and
Gössner W: Cardia cancer: attempt at a therapeutically relevant
classification. Chirurg. 58:25–32. 1987.(In German).
|
|
15
|
Cunningham D, Allum WH, Stenning SP, et
al; MAGIC Trials Participants. Perioperative chemotherapy versus
surgery alone for resectable gastroesophageal cancer. N Engl J Med.
355:11–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ychou M, Boige V, Pignon JP, et al:
Perioperative chemotherapy compared with surgery alone for
resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD
multicenter phase III trial. J Clin Oncol. 29:1715–1721. 2011.
View Article : Google Scholar
|
|
17
|
Tepper J, Krasna MJ, Niedzwiecki D, et al:
Phase III trial of trimodality therapy with cisplatin,
fluorouracil, radiotherapy, and surgery compared with surgery alone
for esophageal cancer: CALGB 9781. J Clin Oncol. 26:1086–1092.
2008. View Article : Google Scholar
|
|
18
|
Medical Research Council Oesophageal
Cancer Working Group. Surgical resection with or without
preoperative chemotherapy in oesophageal cancer: a randomised
controlled trial. Lancet. 359:1727–1733. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Leibl BJ, Vitz S, Schäfer W, Alfrink M,
Gschwendtner A and Grabenbauer GG: Adenocarcinoma of the
esophagogastric junction: neoadjuvant radiochemotherapy and radical
surgery: early results and toxicity. Strahlenther Onkol.
187:231–237. 2011. View Article : Google Scholar
|
|
20
|
Starling N, Okines A, Cunningham D, et al:
A phase II trial of preoperative chemotherapy with epirubicin,
cisplatin and capecitabine for patients with localised
gastro-oesophageal junctional adenocarcinoma. Br J Cancer.
100:1725–1730. 2009. View Article : Google Scholar
|
